,26 CD44 overexpression or alternative splicing was described for various types of cancers including ccRCC and associated with invasion, metastasis, and resistance to chemotherapeutic drugs.27, 28, 29 CD44 is a known cargo of clathrin-independent endocytosis.30 The gene discussed is CD44; the disease is nonpapillary renal cell carcinoma.